{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"apparent-mineralocorticoid-excess","columns":[{"gene":"","key":"population-af4d6991481e3fa62fd7","label":"Apparent mineralocorticoid excess","mondoId":"MONDO:0009025","onsetQualifier":null,"originColumnKey":"MONDO:0009025/OMIM:218030","originalViews":[{"key":"MONDO:0009025/OMIM:218030","label":"Apparent mineralocorticoid excess","scopeLabel":"OMIM:218030","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["37a1ebc15279c2eca250379cef8b2e04fdaa74a6827db688de23914f701a3192","3a92d25a57816bae775afda406f36fe98ff91c7c9436a4479b406aad0d1e3d1a","3ce81c23f17d390d53b4ad18cff458ca414188c246effe866541c28d04065193","3d119370bcd47bfe34cf30fc4ee31dba45ba76fb70fb4a36c694db679a1a17bf","7917f7459e91f8d4f6eba0603cde102b95d843131fd9dcbf3bed46d914b4c349","94bf6b97074728068249ab14f72cbb9520928e4a4d784b0ed0301f9d18891d7a","95bc9fddda9b83310b27325f410dbab86dd4bae6032875d3980e4f5d68537a35","d6f095d5382fe6adb6980d40776c4ab7ed81775571b571e0f86891537df40b14","f41be6dd22141bb301eea1a6a0ba6be76b1e5e5aa56ce14a2ff729499a2cd760","f553876e9fc4835baf8dd6d32015ad68ef370909e1d280a0ed72b5d8eb69a098"],"recordQualifiers":{},"scopeLabel":"OMIM:218030","sourceIds":["OMIM:218030"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."},{"gene":"","key":"population-88774cc7a8151feda63a","label":"Apparent mineralocorticoid excess","mondoId":"MONDO:0009025","onsetQualifier":null,"originColumnKey":"MONDO:0009025/ORPHA:320","originalViews":[{"key":"MONDO:0009025/ORPHA:320","label":"Apparent mineralocorticoid excess","scopeLabel":"ORPHA:320","sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"recordKeys":["0016631116df446d6af5ac687aac6cdffbf906c59bd0741d172422aca4692063","0592357e5830a897207308bda85a6518b11483b9c4efdd5c2e0e9a9b764596ee","261629d47861a7728b084d3c560f04f4ddefae031722996b10d397bc3933cd1d","2b343537322e660dd903d8f8bce9734c19ca27d926ead9531c0dd05288e0e86d","395eea5a9e813bfc9d5d5862781090a941d3b3d8720288ce9552d280eca779fc","4555c7dbedd86576e0e042ca5fec9b51634e8c9a0d537ac2e513e8a0f934fc9e","49d98209f9c145d259b44c64ab20332d591f5ed5e84a57c8e5420aed154928d5","653c66c98fdf2c4927dcadc392b419d022df41d35e4164c1f53ab6e8a1f7a2f6","768f3307664674e90c0a0d3786548976837f81b87336fdef5cf8185933458ad2","99f2eb3bfe9847ea6ed42a213fc13257aef5e5bcda6e97312b5ae0be116c2458","9c5d1f2f7c9c8520e1914bc259d3a7dff3231d8dd591437871452afe652ce50b","a05706477d0cd38cd07ca970e7d14a52cedd01ccfaec0fbed9bb21d1b7bdfeea","c0bec1bfff70ca8a605ea12994147bd38d5551c7b17fcb43c8a9910220351bbb","ec29e9d6904899a922390c693b0603d581e5f397e0674c918f4acbc13378795e","edbfc47e4250736c29bb1ba747f6bd2a6bd313013d0b6232b0a68bf074b99a6e","f01a4079f98219dc301b772e573128173b6314cfe615c646182575dc0b3f84e4","f4ea8ea9c861505cb0c51a602e5ad9f8100954a678ee32dda3d0f67e3ed3579e"],"recordQualifiers":{},"scopeLabel":"ORPHA:320","sourceIds":["ORPHA:320"],"sourceScope":"Native source population. Existing approved source identity; no family evidence is inherited."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-af4d6991481e3fa62fd7","population-88774cc7a8151feda63a"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0012603","HP:0011731","HP:0004319","HP:0003351","HP:0001508","HP:0001510","HP:0000822"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":1,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":27,"sourceGroups":{"omim":6,"orphanet":17,"published":4}},"features":[{"hpoId":"HP:0012603","label":"Abnormal urine sodium concentration","primary":true},{"hpoId":"HP:0011731","label":"Abnormality of circulating cortisol level","primary":true},{"hpoId":"HP:0004319","label":"Decreased circulating aldosterone concentration","primary":true},{"hpoId":"HP:0003351","label":"Decreased circulating renin concentration","primary":true},{"hpoId":"HP:0001508","label":"Failure to thrive","primary":true},{"hpoId":"HP:0001510","label":"Growth delay","primary":true},{"hpoId":"HP:0000822","label":"Hypertension","primary":true},{"hpoId":"HP:0001095","label":"Hypertensive retinopathy","primary":false},{"hpoId":"HP:0002900","label":"Hypokalemia","primary":false},{"hpoId":"HP:0001960","label":"Hypokalemic metabolic alkalosis","primary":false},{"hpoId":"HP:0001511","label":"Intrauterine growth retardation","primary":false},{"hpoId":"HP:0001712","label":"Left ventricular hypertrophy","primary":false},{"hpoId":"HP:0200114","label":"Metabolic alkalosis","primary":false},{"hpoId":"HP:0000121","label":"Nephrocalcinosis","primary":false},{"hpoId":"HP:0001959","label":"Polydipsia","primary":false},{"hpoId":"HP:0000083","label":"Renal insufficiency","primary":false},{"hpoId":"HP:0012606","label":"Renal sodium wasting","primary":false},{"hpoId":"HP:0004322","label":"Short stature","primary":false},{"hpoId":"HP:0001518","label":"Small for gestational age","primary":false},{"hpoId":"HP:0001297","label":"Stroke","primary":false}],"ledeHtml":"A rare form of pseudohyperaldosteronism characterized by very early-onset and severe hypertension, associated with low renin levels and hypoaldosteronism.","mondoId":"MONDO:0009025","node":{"canonicalSlug":"apparent-mineralocorticoid-excess","comparisons":[{"documentSha256":"a123be482645ef24e97738eb05fd8bb5e7bb8f936df158a7e35ef9db303a5c84","key":"legacy-apparent-mineralocorticoid-excess","kind":"legacy","label":"apparent mineralocorticoid excess","memberIds":["MONDO:0009025"],"mondoId":"MONDO:0009025","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/apparent-mineralocorticoid-excess.a123be482645ef24e97738eb05fd8bb5e7bb8f936df158a7e35ef9db303a5c84.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","independentCorroborationEstablished":false,"matchMethod":"automatic-identity-and-attribution","name":"Apparent mineralocorticoid excess","originalSourceId":"ORPHA:320","paragraphs":["A rare form of pseudohyperaldosteronism characterized by very early-onset and severe hypertension, associated with low renin levels and hypoaldosteronism."],"rawAttribution":"MONDO:0009025","reviewed":null,"scope":"exact","source":"GARD","sourceRelease":"2026-10-21T17:04:56Z","upstream":"MONDO:0009025","url":"https://rarediseases.info.nih.gov/diseases/433"},"ownColumnKeys":["population-af4d6991481e3fa62fd7","population-88774cc7a8151feda63a"],"publication":"published","relationships":[{"kind":"parent","label":"adrenal gland disorder","mondoId":"MONDO:0005495","slug":null},{"kind":"parent","label":"steroid inherited metabolic disorder","mondoId":"MONDO:0005523","slug":"steroid-inherited-metabolic-disorder"},{"kind":"parent","label":"syndromic dyslipidemia","mondoId":"MONDO:0015905","slug":null}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"pending"},"records":[{"frequencyKind":"range","key":"0016631116df446d6af5ac687aac6cdffbf906c59bd0741d172422aca4692063","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002900","is_excluded":false,"label":"Hypokalemia","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0592357e5830a897207308bda85a6518b11483b9c4efdd5c2e0e9a9b764596ee","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0000083","is_excluded":false,"label":"Renal insufficiency","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"261629d47861a7728b084d3c560f04f4ddefae031722996b10d397bc3933cd1d","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001712","is_excluded":false,"label":"Left ventricular hypertrophy","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2b343537322e660dd903d8f8bce9734c19ca27d926ead9531c0dd05288e0e86d","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004319","is_excluded":false,"label":"Decreased circulating aldosterone concentration","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"37a1ebc15279c2eca250379cef8b2e04fdaa74a6827db688de23914f701a3192","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:218030","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"OMIM:218030","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"395eea5a9e813bfc9d5d5862781090a941d3b3d8720288ce9552d280eca779fc","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0012603","is_excluded":false,"label":"Abnormal urine sodium concentration","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"3a92d25a57816bae775afda406f36fe98ff91c7c9436a4479b406aad0d1e3d1a","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:218030","disease_name":"Apparent mineralocorticoid excess","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001510","is_excluded":false,"label":"Growth delay","onset_id":null,"reference":"OMIM:218030","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"3ce81c23f17d390d53b4ad18cff458ca414188c246effe866541c28d04065193","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"OMIM:218030","disease_name":"Apparent mineralocorticoid excess","evidence":"PCS","frequency_raw":"9/9","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"PMID:7670488","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"3d119370bcd47bfe34cf30fc4ee31dba45ba76fb70fb4a36c694db679a1a17bf","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:218030","disease_name":"Apparent mineralocorticoid excess","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0004319","is_excluded":false,"label":"Decreased circulating aldosterone concentration","onset_id":null,"reference":"PMID:7670488","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"4555c7dbedd86576e0e042ca5fec9b51634e8c9a0d537ac2e513e8a0f934fc9e","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"49d98209f9c145d259b44c64ab20332d591f5ed5e84a57c8e5420aed154928d5","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000121","is_excluded":false,"label":"Nephrocalcinosis","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"653c66c98fdf2c4927dcadc392b419d022df41d35e4164c1f53ab6e8a1f7a2f6","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000822","is_excluded":false,"label":"Hypertension","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"768f3307664674e90c0a0d3786548976837f81b87336fdef5cf8185933458ad2","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001508","is_excluded":false,"label":"Failure to thrive","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"7917f7459e91f8d4f6eba0603cde102b95d843131fd9dcbf3bed46d914b4c349","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:218030","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0200114","is_excluded":false,"label":"Metabolic alkalosis","onset_id":null,"reference":"OMIM:218030","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"94bf6b97074728068249ab14f72cbb9520928e4a4d784b0ed0301f9d18891d7a","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:218030","disease_name":"Apparent mineralocorticoid excess","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0002900","is_excluded":false,"label":"Hypokalemia","onset_id":null,"reference":"PMID:7670488","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"95bc9fddda9b83310b27325f410dbab86dd4bae6032875d3980e4f5d68537a35","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:218030","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001518","is_excluded":false,"label":"Small for gestational age","onset_id":null,"reference":"OMIM:218030","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"99f2eb3bfe9847ea6ed42a213fc13257aef5e5bcda6e97312b5ae0be116c2458","raw":{"aspect":"P","body_system":"cardiovascular","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001297","is_excluded":false,"label":"Stroke","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9c5d1f2f7c9c8520e1914bc259d3a7dff3231d8dd591437871452afe652ce50b","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001959","is_excluded":false,"label":"Polydipsia","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"a05706477d0cd38cd07ca970e7d14a52cedd01ccfaec0fbed9bb21d1b7bdfeea","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001960","is_excluded":false,"label":"Hypokalemic metabolic alkalosis","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c0bec1bfff70ca8a605ea12994147bd38d5551c7b17fcb43c8a9910220351bbb","raw":{"aspect":"P","body_system":"eye","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001095","is_excluded":false,"label":"Hypertensive retinopathy","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"d6f095d5382fe6adb6980d40776c4ab7ed81775571b571e0f86891537df40b14","raw":{"aspect":"P","body_system":"growth","disease_id":"OMIM:218030","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0004322","is_excluded":false,"label":"Short stature","onset_id":null,"reference":"OMIM:218030","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"ec29e9d6904899a922390c693b0603d581e5f397e0674c918f4acbc13378795e","raw":{"aspect":"P","body_system":"metabolic","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0012606","is_excluded":true,"label":"Renal sodium wasting","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"edbfc47e4250736c29bb1ba747f6bd2a6bd313013d0b6232b0a68bf074b99a6e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0003351","is_excluded":false,"label":"Decreased circulating renin concentration","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f01a4079f98219dc301b772e573128173b6314cfe615c646182575dc0b3f84e4","raw":{"aspect":"P","body_system":"growth","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001511","is_excluded":false,"label":"Intrauterine growth retardation","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"f41be6dd22141bb301eea1a6a0ba6be76b1e5e5aa56ce14a2ff729499a2cd760","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:218030","disease_name":"Apparent mineralocorticoid excess","evidence":"IEA","frequency_raw":null,"hpo_id":"HP:0001095","is_excluded":false,"label":"Hypertensive retinopathy","onset_id":null,"reference":"OMIM:218030","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"range","key":"f4ea8ea9c861505cb0c51a602e5ad9f8100954a678ee32dda3d0f67e3ed3579e","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:320","disease_name":"Apparent mineralocorticoid excess","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0011731","is_excluded":false,"label":"Abnormality of circulating cortisol level","onset_id":null,"reference":"ORPHA:320","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"reported","key":"f553876e9fc4835baf8dd6d32015ad68ef370909e1d280a0ed72b5d8eb69a098","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:218030","disease_name":"Apparent mineralocorticoid excess","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003351","is_excluded":false,"label":"Decreased circulating renin concentration","onset_id":null,"reference":"PMID:7670488","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/433\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009025\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-identity-and-attribution</dd><dt>Upstream attribution</dt><dd>MONDO:0009025</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>A rare form of pseudohyperaldosteronism characterized by very early-onset and severe hypertension, associated with low renin levels and hypoaldosteronism.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/433\" rel=\"noreferrer\">GARD</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"apparent-mineralocorticoid-excess","sourceDocuments":[{"name":"GARD: Apparent mineralocorticoid excess","reviewed":null,"source_release":"2026-10-21T17:04:56Z","url":"https://rarediseases.info.nih.gov/diseases/433"},{"name":"MONDO: apparent mineralocorticoid excess","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009025"}],"sourceNote":"","synonyms":["11 Beta-hydroxysteroid dehydrogenase type 2 deficiency","11-beta-hydroxysteroid dehydrogenase deficiency type 2","AME","AME 1","APE","apparent mineralocorticoid excess","apparent mineralocorticoid excess syndrome","cortisol 11-beta-ketoreductase deficiency","syndrome of apparent mineralocorticoid Excess","Ulick syndrome"],"takeawayHtml":"","title":"apparent mineralocorticoid excess"},"schemaVersion":1}
